Metabolic syndrome and smoking are associated with future development of advanced chronic kidney disease in older adults

CardioRenal Medicine

Volumn 6, Issue 2, 2015, Pages 108-115

  Zammit, Andrea R ^a   Katz, Mindy J ^a   Derby, Carol ^a   Bitzer, Markus ^b   Lipton, Richard B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chronic kidney disease; Metabolic syndrome; Smoking

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMMUNITY LIVING; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; WAIST CIRCUMFERENCE;

EID: 84974575134     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000441624     Document Type: Article

References (26)

1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 2002; 39 Supplement 1:S46-S75.
2. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 suppl 1):S1-S266.
3. Coresh J, Selvin E, Stevens L, et al: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
5. United States Renal Data System: Annual Data Report: An Overview of the Epidemiology of Kidney Disease in the United States, 2014. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014. http://www.usrds.org.
6. Gregg EW, Cheng YJ, Cadwell BL, et al: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 1868-1874.
7. Mokdad AH, Ford ES, Bowman BA, et al: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
8. Islam TM, Fox CS, Mann D, Muntner P: Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol 2009; 10: 17.
9. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
10. Hou X, Wang C, Zhang X, et al: Triglyceride levels are closely associated with mild declines in estimated glomerular filtration rates in middle-aged and elderly Chinese with normal serum lipid levels. PLoS One 2014; 9:e106778.
11. Zhang L, Yuan Z, Chen W, et al: Serum lipid profiles, lipid ratios and chronic kidney disease in a Chinese population. Int J Environ Res Public Health 2014; 11: 7622-7635.
12. Kaseda R, Jabs K, Hunley TE, et al: Dysfunctional high-density lipoproteins in children with chronic kidney disease. Metabolism 2015; 64: 263-273.
13. Chen J, Muntner P, Hamm LL, et al: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174.
14. Katz MJ, Lipton RB, Hall CB, et al: Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: A report from the Einstein Aging Study. Alzheimer Dis Assoc Disord 2012; 26: 335-343.
15. Levey AS, Bosch JP, Breyer Lewis J, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470.
16. Cirillo M, Anastasio P, De Santo NG: Relationship of gender, age and body mass index to errors in predicting kidney function. Nephrol Dial Transplant 2005; 20: 1791-1798.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
19. Chen J, Gu D, Chen C-S, et al: Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007; 22: 1100-1106.
20. Kurella M, Chertow GM, Fried LF, et al: Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 2005; 16: 2127-2133.
21. Lucove J, Vupputuri S, Heiss G, North K, Russell M: Metabolic syndrome and the development of CKD in American Indians: The Strong Heart Study. Am J Kidney Dis 2008; 51: 21-28.
22. Orth SR, Hallan SI: Smoking: A risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients-absence of evidence or evidence of absence? Clin J Am Soc Nephrol 2008; 3: 226-236.
23. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A: Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int 2007; 71: 159-166.
24. Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, Grigoletto F; ILSA Working Group: Atherosclerotic risk factors and renal function in the elderly: The role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 2005; 20: 114-123.
25. Joshi VD, Mooppil N, Lim J: Prevalence and risk factors of undetected proteinuria in an elderly South-East Asian population. Nephrology (Carlton) 2006; 11: 347-354.
26. Bleyer AJ, Shemanski LR, Burke GL, et al: Tobacco, hypertension, and vascular disease: Risk factors for renal dysfunctional decline in an older population. Kidney Int 2000; 57: 2072-2079.